Atezolizumab vs Irbesartan

## Atezolizumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Irbesartan**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Irbesartan — 11-15 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Irbesartan — C25H28N6O.

**Molecular Weight**: Atezolizumab — N/A; Irbesartan — 428.5320 g/mol.

**Type**: Atezolizumab — Antibody; Irbesartan — Small molecule.